Omiganan vs Pyrrhocoricin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Omiganan (CLS001, MBI-226) is a synthetic analog of indolicidin, a bovine neutrophil AMP. It was developed for topical antimicrobial applications including acne vulgaris, catheter-site infection prevention, and rosacea....
Calculate Omiganan dose →Pyrrhocoricin is a proline-rich antimicrobial peptide from the hemipteran insect Pyrrhocoris apterus (firebug). Unlike membrane-lytic AMPs, pyrrhocoricin exerts its effects by penetrating bacterial cells and interfering with intracellular targets, specifically the bacterial heat ...
Calculate Pyrrhocoricin dose →| Parameter | Omiganan | Pyrrhocoricin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Phase 3 (Completed) | Preclinical |
| Half-Life | Hours (topical) | Short |
| Typical Dose | 1-3% gel | N/A (research only) |
| Frequency | Twice daily | N/A |
| Route | Topical gel/cream | Systemic (research) |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.